Are you a new member? Sign up now
Login area
| Sign up
close
NPLATE - 250mcg - 1
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B02BX04 | BioTech | Romiplostim - 250mcg | 7521 | 186525/13 | NPLATE | 250mcg | 1 | Injectable powder for solution | SC | Mersaco | Amgen Europe BV | The Netherlands | 67,369,332 L.L | 10.71 | E1 | Amgen Europe BV | The Netherlands | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B02BX04 | BioTech | Romiplostim - 250mcg | 7521/388 | 186525/13 | NPLATE | 250mcg | 1 | Injectable powder for solution | SC | Mersaco | Amgen Europe BV | The Netherlands | L.L | 10.71 | E1 | Amgen Europe BV | The Netherlands | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024